Skip to content
Menu

RegeneRx Biopharmaceuticals, Inc. RGRX

Full chart Compare
Set alert

Price alert · RGRX

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

0.161 Day range 0.161
0.0002 52-week range 0.163
YTD
+266.67%
1 year
+450.00%

RGRX revenue history

Revenue is income from the company’s ordinary business activities.

76,761 USD

FY 2022 · Period ended

Coverage: stale. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20222022-12-3176,76100.00%
FY 20212021-12-3176,76100.00%
FY 20202020-12-3176,761-1-0.00%
FY 20192019-12-3176,7627,09510.18%
FY 20182018-12-3169,66713,01522.97%
FY 20172017-12-3156,652-36,656-39.28%
FY 20162016-12-3193,30832,69653.94%
FY 20152015-12-3160,61260,612Not meaningful
FY 20142014-12-310-29,484-100.00%
FY 20132013-12-3129,484-1,313,360-97.80%
FY 20122012-12-311,342,844-168,728-11.16%
FY 20112011-12-311,511,572662,03377.93%
FY 20102010-12-31849,539849,539Not meaningful
FY 20092009-12-310-168,412-100.00%
FY 20082008-12-31168,412-71,912-29.92%
FY 20072007-12-31240,324-32,167-11.80%
FY 20062006-12-31272,491272,491Not meaningful
FY 20052005-12-3100Not meaningful
FY 20042004-12-3100Not meaningful
FY 20032003-12-3100Not meaningful
FY 20022002-12-3100Not meaningful
FY 20012001-12-3100Not meaningful
FY 20002000-12-3100Not meaningful
FY 19991999-12-310-3,265-100.00%
FY 19981998-12-313,265-211,769-98.48%
FY 19971997-12-31215,034-327,209-60.34%
FY 19961996-12-31542,243436,652413.53%
FY 19951995-12-31105,591-614,792-85.34%
FY 19941994-12-31720,383Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2025-01-04T21:01:35.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.